Arlington Trust’s Elevance Health ELV Stock Holding History

Arlington Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.11K	Sell	8 -25	-76%	-$10K	﹤0.01%	705
2026 Q2	$12.8K	Buy	33 +27	+450%	+$10K	﹤0.01%	435
2026 Q1	$1.76K	Buy	+6	New	+$1.97K	﹤0.01%	657
2025 Q4	–	Sell	-390	Closed	-$126K	–	498
2025 Q3	$126K	Hold	390	–	–	0.02%	241
2025 Q2	$152K	Sell	390 -182	-32%	-$73.2K	0.03%	203
2025 Q1	$249K	Sell	572 -316	-36%	-$127K	0.05%	151
2024 Q4	$328K	Buy	888 +146	+20%	+$61.1K	0.07%	125
2024 Q3	$386K	Hold	742	–	–	0.08%	109
2024 Q2	$402K	Sell	742 -32	-4%	-$16.9K	0.09%	98
2024 Q1	$401K	Sell	774 -5	-0.6%	-$2.49K	0.1%	97
2023 Q4	$367K	Buy	+779	New	+$360K	0.1%	96

Other funds holding ELV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Focused Investors Los Angeles, California $2.41B AUM 10.28% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Arlington Trust's ELV Position: Q3 2026 in Review

Arlington Trust reduced its Elevance Health (ELV) stake by 76% in Q3 2026, selling an estimated $10K and leaving 8 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Arlington Trust first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $402K in Q2 2024. 595 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Arlington Trust held 8 shares of Elevance Health worth $3.11K as of Q3 2026.
Arlington Trust sold 25 Elevance Health shares in Q3 2026, an estimated $10K.
Elevance Health made up ﹤0.01% of Arlington Trust's portfolio in Q3 2026, its #705 holding.
Arlington Trust first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
Arlington Trust's Elevance Health position peaked at $402K in Q2 2024.
595 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.